| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Charles L Bowde. Treatment options for bipolar depression. The Journal of clinical psychiatry. vol 66 Suppl 1. 2005-03-10. PMID:15693745. |
from the data so far, the rates of induction of mania for selective serotonin reuptake inhibitors and lamotrigine seem similar to those seen with placebo. |
2005-03-10 |
2023-08-12 |
human |
| Alan F Schatzber. Employing pharmacologic treatment of bipolar disorder to greatest effect. The Journal of clinical psychiatry. vol 65 Suppl 15. 2005-01-18. PMID:15554791. |
atypical antipsychotics with the dual effect of blocking dopamine and serotonin receptors in the brain decrease psychosis, mania, and, according to some preliminary indications, possibly depression. |
2005-01-18 |
2023-08-12 |
Not clear |
| Tommi Tolmunen, Mikko Joensuu, Pirjo Irmeli Saarinen, Hanna Mussalo, Pasi Ahola, Ritva Vanninen, Jyrki Kuikka, Jari Tiihonen, Johannes Lehtone. Elevated midbrain serotonin transporter availability in mixed mania: a case report. BMC psychiatry. vol 4. 2004-12-30. PMID:15363105. |
elevated midbrain serotonin transporter availability in mixed mania: a case report. |
2004-12-30 |
2023-08-12 |
Not clear |
| Guy Chouinar. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. The Journal of clinical psychiatry. vol 65 Suppl 5. 2004-05-11. PMID:15078112. |
they were found to be effective in treating panic disorder and panic attacks with or without agoraphobia, as add-on therapy to selective serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder and panic disorders, and as adjunctive therapy in treating patients with acute mania or acute agitation. |
2004-05-11 |
2023-08-12 |
Not clear |
| A Rousseva, C Henry, D van den Bulke, G Fournier, J-L Laplanche, M Leboyer, F Bellivier, J-M Aubry, P Baud, M Boucherie, C Buresi, F Ferrero, A Malafoss. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. The pharmacogenomics journal. vol 3. issue 2. 2004-01-07. PMID:12746735. |
antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. |
2004-01-07 |
2023-08-12 |
Not clear |
| A Rousseva, C Henry, D van den Bulke, G Fournier, J-L Laplanche, M Leboyer, F Bellivier, J-M Aubry, P Baud, M Boucherie, C Buresi, F Ferrero, A Malafoss. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. The pharmacogenomics journal. vol 3. issue 2. 2004-01-07. PMID:12746735. |
we studied a functional polymorphism of the serotonin transporter (5-htt) gene (a 44 bp insertion/deletion in the 5-htt-linked polymorphic region (5-httlpr)) and lifetime history of antidepressant-induced mania (aim) in a population of 305 patients with bipolar affective disorder. |
2004-01-07 |
2023-08-12 |
Not clear |
| D N Mendhekar, D Gupta, V Girotr. Sertraline-induced hypomania: a genuine side-effect. Acta psychiatrica Scandinavica. vol 108. issue 1. 2003-11-21. PMID:12807380. |
antidepressants including selective serotonin reuptake inhibitor (ssri)-associated mania or hypomania has been well documented in the literature but these patients with switch have either mood disorders or various risk factors for bipolar disorder. |
2003-11-21 |
2023-08-12 |
Not clear |
| Roy H Perlis, David Mischoulon, Jordan W Smoller, Yu-Jui Yvonne Wan, Stefania Lamon-Fava, Keh-Ming Lin, Jerrold F Rosenbaum, Maurizio Fav. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biological psychiatry. vol 54. issue 9. 2003-11-21. PMID:14573314. |
the short (s) allele of the serotonin transporter gene-linked polymorphic region (5httlpr) has been associated with poorer antidepressant response in major depressive disorder (mdd) and with antidepressant-induced mania. |
2003-11-21 |
2023-08-12 |
Not clear |
| Gordon Bates, Susie Wynne Willso. 'Use of selective serotonin reuptake inhibitors in children with pervasive developmental disorder: risk of treatment emergent mania'. Developmental medicine and child neurology. vol 45. issue 5. 2003-05-15. PMID:12729153. |
'use of selective serotonin reuptake inhibitors in children with pervasive developmental disorder: risk of treatment emergent mania'. |
2003-05-15 |
2023-08-12 |
Not clear |
| M Fink, M A Taylo. The many varieties of catatonia. European archives of psychiatry and clinical neuroscience. vol 251 Suppl 1. 2002-03-07. PMID:11776271. |
the commonality in response indicates that catatonia, malignant catatonia, neuroleptic malignant syndrome, toxic serotonin syndrome, delirious mania, catatonic excitement, benign stupor, and oneirophrenia are best evaluated as diverse manifestations of one syndrome for clinical and neuroscience research purposes. |
2002-03-07 |
2023-08-12 |
Not clear |
| E Mundo, M Walker, T Cate, F Macciardi, J L Kenned. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. Archives of general psychiatry. vol 58. issue 6. 2001-06-28. PMID:11386982. |
the role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. |
2001-06-28 |
2023-08-12 |
Not clear |
| I S Shiah, L N Yatha. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar disorders. vol 2. issue 2. 2001-04-12. PMID:11252655. |
serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. |
2001-04-12 |
2023-08-12 |
Not clear |
| I S Shiah, L N Yatha. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar disorders. vol 2. issue 2. 2001-04-12. PMID:11252655. |
although extensive evidence has accumulated since then to support 5-ht's role in depression, relatively fewer studies examined its role in mania. |
2001-04-12 |
2023-08-12 |
Not clear |
| I S Shiah, L N Yatha. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar disorders. vol 2. issue 2. 2001-04-12. PMID:11252655. |
the purpose of this paper was to review and summarize the current state of knowledge on the role of 5-ht in mania and its treatment. |
2001-04-12 |
2023-08-12 |
Not clear |
| W A Nolen, D Bloemkol. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm. Neuropsychobiology. vol 42 Suppl 1. 2001-02-08. PMID:11093064. |
the switch ratio into (hypo)mania by tricyclic antidepressants seems to be higher than by several other antidepressants, especially the selective serotonin reuptake inhibitors. |
2001-02-08 |
2023-08-12 |
Not clear |
| H J Möller, H Grunz. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? European archives of psychiatry and clinical neuroscience. vol 250. issue 2. 2000-10-10. PMID:10853919. |
furthermore, the fact that apparently the selective serotonin re-uptake inhibitors and possibly some other modern antidepressants have only a low risk of inducing a switch to mania should stimulate a rewriting of the guidelines on drug treatment in acute bipolar depression in a less restrictive way concerning the use of antidepressants. |
2000-10-10 |
2023-08-12 |
Not clear |
| Y Barak, R Kimhi, R Weizma. Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients? International clinical psychopharmacology. vol 15. issue 1. 2000-09-25. PMID:10836288. |
to determine whether selectivity for serotonin reuptake plays a role in antidepressant-associated mania (aam), we evaluated the frequency of treatment-emergent mania in patients with unipolar depression who received either citalopram, a highly selective serotonin uptake inhibitor, or the adrenergic tetracyclic antidepressants (ttcas) maproriline and mianserin, or placebo. |
2000-09-25 |
2023-08-12 |
Not clear |
| A Fugh-Berma. Herb-drug interactions. Lancet (London, England). vol 355. issue 9198. 2000-02-25. PMID:10675182. |
plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (ginkgo biloba), garlic (allium sativum), dong quai (angelica sinensis), or danshen (salvia miltiorrhiza); mild serotonin syndrome in patients who mix st john's wort (hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with st john's wort; induction of mania in depressed patients who mix antidepressants and panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the ayurvedic syrup shankhapushpi. |
2000-02-25 |
2023-08-12 |
Not clear |
| J Nelson, G Chouinar. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique. vol 6. issue 2. 1999-11-22. PMID:10519733. |
in multiple therapy, benzodiazepines augment the efficacy of other drugs such as lithium in mania, antipsychotics in psychotic agitation and selective serotonin reuptake inhibitors in panic disorder. |
1999-11-22 |
2023-08-12 |
Not clear |
| A Velayudhan, T A Sunitha, S Balachander, J Y Reddy, S Khann. A study of platelet serotonin receptor in mania. Biological psychiatry. vol 45. issue 8. 1999-09-02. PMID:10386192. |
serotonergic (5-ht) dysfunction has been hypothesized in mania; however platelet studies on the 5-ht uptake rate and the 5-ht transporter have revealed inconsistent results. |
1999-09-02 |
2023-08-12 |
Not clear |